Shown: posts 1 to 6 of 6. This is the beginning of the thread.
Posted by Buckeye Fan on June 2, 2004, at 19:21:30
What a mess.
http://aolsvc.news.aol.com/business/article.adp?id=20031203103209990018
Posted by sl on June 4, 2004, at 10:38:02
In reply to Money and the deciet of the Drug Companies, posted by Buckeye Fan on June 2, 2004, at 19:21:30
Dude we can't see that unless we sign up for an AOL account/membership. Perhaps you could post the article instead.
Posted by Carlos C on June 5, 2004, at 2:48:33
In reply to Money and the deciet of the Drug Companies, posted by Buckeye Fan on June 2, 2004, at 19:21:30
This is a surprise to you?
Posted by Buckeye Fan on June 5, 2004, at 16:08:21
In reply to Re: Money and the deciet of the Drug Companies » Buckeye Fan, posted by Carlos C on June 5, 2004, at 2:48:33
Spitzer Sues GlaxoSmithKline Over Paxil Use in Children
Says Firm Hid Studies Suggesting a Possible Increase of Suicidal Thinking in Children
By THERESA AGOVINO, APNEW YORK (June 2) - GlaxoSmithKline PLC committed fraud by withholding negative information and misrepresenting data on prescribing its antidepressant Paxil to children, according to a lawsuit filed Wednesday by New York Attorney General Eliot Spitzer.
New York State Attorney General Eliot Spitzer
The lawsuit, filed in New York State Supreme Court, said Glaxo suppressed four studies that failed to demonstrate the drug was effective in treating children and adolescents and suggested a possible increase of suicidal thinking and acts.It also said an internal 1999 Glaxo document showed that the company intended to ''manage the dissemination of data in order to minimize any potential negative commercial impact.''
Glaxo spokeswoman Mary Anne Rhyne said the company ''has acted responsibly in conducting the studies in pediatric patients and disseminating results. All of our studies have been made available to the (U.S. Food and Drug Administration) and regulators worldwide.''
Rhyne also said the studies referred to in the suit have been made public in medical meetings, journals and letters to doctors. She said the internal document referenced in the suit ''is inaccurate and inconsistent with the facts, and doesn't express the overall company position.''
The lawsuit touches on two pharmaceutical and medical controversies: whether antidepressants increase suicidal tendencies in children, and if drug companies should be required to disclose all studies they conduct on their medicines.Paxil is not approved for use in children, but doctors can prescribe drugs as they see fit and routinely recommend antidepressants for children suffering from depression and other psychological disorders.
Only Prozac, which is made by Eli Lilly & Co., has been approved for use in children. According to Spitzer, Glaxo's revenues for Paxil prescriptions in children and adolescents totaled $55 million in 2002.
The lawsuit seeks the return of all profits obtained by Glaxo as a result of conduct alleged in the suit.
Posted by sl on June 6, 2004, at 9:54:58
In reply to Re: Money and the deciet of the Drug Companies, posted by Buckeye Fan on June 5, 2004, at 16:08:21
Wow.
The world of prescription medicine is a cut-throat business, I guess.
Posted by Dr. Bob on June 6, 2004, at 10:58:37
In reply to Re: Money and the deciet of the Drug Companies, posted by sl on June 6, 2004, at 9:54:58
> The world of prescription medicine is a cut-throat business, I guess.
Sorry to interrupt, but I'd like to redirect follow-ups regarding the prescription medicine business to Psycho-Social-Babble. Here's a link:
http://www.dr-bob.org/babble/social/20040602/msgs/354265.html
Thanks,
Bob
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.